Currently, there are very few studies elucidating the role of CYP1A2 as an AA epoxygenase in cancer development or progression, however, it remains possible that the formation of the pro-angiogenic EETs by CYP1A2 can play a role in lung cancer progression. This evidence concerns the gene CYP1A2 and lung cancer.